IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 68 filers reported holding IRADIMED CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,000 | – | 61 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 234,810 | $5,013,000 | 5.83% |
| Nine Ten Capital Management LLC | 277,088 | $5,916,000 | 2.51% |
| RK Capital | 211,325 | $4,512,000 | 2.03% |
| Parkman Healthcare Partners LLC | 113,855 | $2,431,000 | 1.13% |
| Ranger Investment Management | 235,312 | $5,024,000 | 0.44% |
| CADENCE CAPITAL MANAGEMENT LLC | 101,720 | $2,172,000 | 0.37% |
| ALGERT GLOBAL LLC | 30,152 | $644,000 | 0.27% |
| Mondrian Investment Partners LTD | 163,939 | $3,500,000 | 0.12% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $444,000 | 0.10% |
| GLOBEFLEX CAPITAL L P | 15,510 | $331,000 | 0.10% |